United Therapeutics (UTHR) Surpasses Q4 Earnings and Revenue Estimates

United Therapeutics (UTHR) came out with quarterly earnings of $6.19 per share, beating the Zacks Consensus Estimate of$ 6.10 per share. This compares to earnings of $4.36 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 1.48%. A quarter ago, it was expected that this drugmaker would post earnings of$ 6.18 per share when it actually produced earnings of $6.39, delivering a surprise of 3.40%.Over the last four quarters, the comp ...